Nvidia leads S&P's winners in 2016; drug companies slump


This Oct. 10, 2013, file photo, shows an EpiPen epinephrine auto-injector, a Mylan product, in Hendersonville, Texas. Five of the 10 largest losses on the S&P 500 in 2016 went to drug companies.



from Biotech News